Abstract Details

Title UWA-0121, a Novel Dopamine and Serotonin Re-Uptake Inhibitor, Increases Quality and Duration of L-DOPA Anti-Parkinsonian Actions in the MPTP-Lesioned Primate Model of Parkinson[apos]s Disease

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 004

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Philippe Huot, MD (CHUM Research Centre)	No disclosure on file
Tom H. Johnston, PhD (Toronto Western Research Institute)	No disclosure on file
	No disclosure on file
	No disclosure on file
Susan Fox, MD, FAAN (Toronto Western Hospital)	The institution of Dr. Fox has received research support from MJFF/Safra. The institution of Dr. Fox has received research support from Parkinson Canada. The institution of Dr. Fox has received research support from NIH. Dr. Fox has received publishing royalties from a publication relating to health care.
	No disclosure on file
Varun Naragum, MD (Boston University Medical Center)	No disclosure on file
Jonathan M. Brotchie, PhD (Clinical Studies Research Cen/ TWH)	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��